This page lists the SEC filings reported by Casdin Capital, LLC.
| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13G | 2024-04-18 | Casdin Capital, LLC | Century Therapeutics, Inc. | 5,190,506 | 6.1% | EDGAR |
| SC 13D/A | 2024-04-08 | Casdin Capital, LLC | Century Therapeutics, Inc. | 3,206,380 | 5.0% | EDGAR |
| SC 13D/A | 2024-03-20 | Casdin Capital, LLC | STANDARD BIOTOOLS INC. | 61,907,605 | 16.2% | EDGAR |
| SC 13G/A | 2024-02-14 | Casdin Capital, LLC | Relay Therapeutics, Inc. | 7,387,943 | 6.0% | EDGAR |
| SC 13G/A | 2024-02-14 | Casdin Capital, LLC | MAXCYTE, INC. | 0 | 0.0% | EDGAR |
| SC 13D/A | 2024-01-09 | Casdin Capital, LLC | STANDARD BIOTOOLS INC. | 52,773,091 | 16.2% | EDGAR |
| SC 13D/A | 2023-11-15 | Casdin Capital, LLC | EQRx, Inc. | 0 | 0.0% | EDGAR |
| SC 13D/A | 2023-10-24 | Casdin Capital, LLC | BIOLIFE SOLUTIONS INC | 8,707,165 | 19.5% | EDGAR |
| SC 13G | 2023-10-02 | Casdin Capital, LLC | Relay Therapeutics, Inc. | 6,298,574 | 5.2% | EDGAR |
| SC 13D/A | 2023-05-08 | Casdin Capital, LLC | Absci Corp | 4,448,260 | 4.8% | EDGAR |
| SC 13D/A | 2023-03-20 | Casdin Capital, LLC | Absci Corp | 5,533,260 | 6.0% | EDGAR |
| SC 13G/A | 2023-02-14 | Casdin Capital, LLC | Verve Therapeutics, Inc. | 2,290,571 | 3.7% | EDGAR |
| SC 13G/A | 2023-02-14 | Casdin Capital, LLC | CODEXIS, INC. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2023-02-14 | Casdin Capital, LLC | Magenta Therapeutics, Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2023-02-14 | Casdin Capital, LLC | Invitae Corp | 9,038,388 | 3.7% | EDGAR |
| SC 13G/A | 2023-02-14 | Casdin Capital, LLC | Tango Therapeutics, Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2023-02-14 | Casdin Capital, LLC | DermTech, Inc. | 0 | 0.0% | EDGAR |
| SC 13D/A | 2023-02-13 | Casdin Capital, LLC | Absci Corp | 6,473,260 | 7.0% | EDGAR |
| SC 13G/A | 2023-01-10 | Casdin Capital, LLC | MAXCYTE, INC. | 9,220,000 | 9.0% | EDGAR |
| SC 13D/A | 2022-12-07 | Casdin Capital, LLC | Tenaya Therapeutics, Inc. | 6,427,200 | 9.9% | EDGAR |
- Form 13F-HR
- The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
- Form SC 13D/G
- Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
- Form 3, 4, and 5
- Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.